Finding 522497 (2022-005)

Significant Deficiency
Requirement
A
Questioned Costs
-
Year
2022
Accepted
2025-02-10

AI Summary

  • Core Issue: Lack of documented review and approval for 22 out of 40 tested COVID-related expenditures, despite them being allowable costs.
  • Impacted Requirements: Compliance with Uniform Guidance for internal controls and proper authorization of payments.
  • Recommended Follow-Up: Assess and enhance policies for disbursement reviews and approvals to strengthen internal controls by June 30, 2025.

Finding Text

Assistance Listing Number: 93.498 COVID-19 - Provider Relief Fund and American Rescue Plan (ARP) Rural DistributionFederal Agency: U.S. Department of Health and Human Services Pass-Through Agency: Not applicableAward Number / Year: N/A / 2022 Compliance Requirements: Activities Allowed or Unallowed/ Allowable Costs Criteria: As outlined in Pub. L. No. 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623, funds are appropriated to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. That funds appropriated under this paragraph in this Act shall be available for building or construction of temporary structures, leasing of properties, medical supplies and equipment, including personal protective equipment and testing supplies, increased workforce and trainings, emergency operation centers, retrofitting facilities and surge capacity. Uniform Guidance requires that charges to federal awards must be based on records that are supported by a system of internal controls that provide reasonable assurance about the accuracy, allowability and proper allocation of the charges. Condition and Context: During our testing, we noted that 22 expenditure samples out of 40 tested for covid related expenses were supported by invoices that were for allowable expenses, but there was no evidence of review and approval by an appropriate individual for proper authorization of payment. This was not a statistically valid sample.Effect: Although the underlying expenses are allowable expenditures under the provider relief program, the support was not maintained to document to approval as required by Uniform Guidance, therefore this is considered a significant deficiency in internal controls.Questioned Cost: None Cause: The Center does not have an adequate polices and systems needed to implement a properly designed system of controls over these significant transaction cycles. Recommendation: Policies and procedures related to review and approval around disbursements should be assessed to determine whether additional review procedures or further segregation of duties are feasible.Management’s Response: Management agrees with the finding. While we have policies and procedures as recommended by the auditors, there is an opportunity to review our policies and procedures related to the review and approval around disbursements. Through the leadership of our Chief Financial Officer and our Director of Finance, our internal control policies and procedures will be evaluated and as needed, amended, with an effective date no later than June 30, 2025.

Corrective Action Plan

Corrective Action: Management agrees with the findings. While we have policies and procedures as recommended by the auditors, there is an opportunity to review our policies and procedures related to the review and approval around disbursements. Through the leadership of our Chief Financial Officer and our Director of Finance, our internal control policies and procedures will be evaluated and as needed, amended, with an effective date no later than June 30, 2025. Anticipated Completion Date: June 30, 2025 Contact Person: Marco Giordano, Vice President and Chief Financial Officer

Categories

Allowable Costs / Cost Principles Internal Control / Segregation of Duties Significant Deficiency Equipment & Real Property Management

Other Findings in this Audit

  • 522496 2022-004
    Significant Deficiency
  • 1098938 2022-004
    Significant Deficiency
  • 1098939 2022-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $759,395
93.959 Block Grants for Prevention and Treatment of Substance Abuse $79,100